0001104659-17-017611.txt : 20170317
0001104659-17-017611.hdr.sgml : 20170317
20170317161723
ACCESSION NUMBER: 0001104659-17-017611
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170315
FILED AS OF DATE: 20170317
DATE AS OF CHANGE: 20170317
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aralez Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660719
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
BUSINESS PHONE: 905-876-1118
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUDNICK SETH
CENTRAL INDEX KEY: 0001184420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37691
FILM NUMBER: 17698201
MAIL ADDRESS:
STREET 1: 7100 WEST CREDIT AVENUE, SUITE 101
STREET 2: C/O ARALEZ PHARMACEUTICALS
CITY: MISSISSAUGA
STATE: A6
ZIP: L5N 0E4
4
1
a4.xml
4
X0306
4
2017-03-15
0
0001660719
Aralez Pharmaceuticals Inc.
ARLZ
0001184420
RUDNICK SETH
C/O ARALEZ PHARMACEUTICALS INC.,
7100 WEST CREDIT AVENUE, SUITE 101
MISSISSAUGA
A6
L5N 0E4
ONTARIO, CANADA
1
0
0
0
Common Shares, without par value
2017-03-15
4
P
0
15000
2.2633
A
79391
D
Common Shares, without par value
30000
I
By Trust
This transaction was executed in two trades at prices of $2.21 and $2.37. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
/s/ Eric L. Trachtenberg, attorney-in-fact for Seth Rudnick
2017-03-17